ATXN2 and amyotrophic lateral sclerosis: ATXN2 trinucleotide CAG repeats were analyzed in 1474 ALS cases and 567 neurologically normal controls from the UK and in 1328 ALS cases and 691 neurologically normal controls from the Netherlands.